#neurology #Neurodegeneration #biotech #ADpatients #dosingregimen #LEQEMBI #earlyAlzheimersdisease #Eisai #BiogenInc #phase2Study201 #ClarityADstudy #amyloidbetaplaques #amyloidbetaplaqueclearance #SupplementalBiologicsLicenseApplication #subcutaneousautoinjector
pharmatimes.com/news/fda-app...
0
0
0
0